EA200200630A1 - Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления - Google Patents

Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления

Info

Publication number
EA200200630A1
EA200200630A1 EA200200630A EA200200630A EA200200630A1 EA 200200630 A1 EA200200630 A1 EA 200200630A1 EA 200200630 A EA200200630 A EA 200200630A EA 200200630 A EA200200630 A EA 200200630A EA 200200630 A1 EA200200630 A1 EA 200200630A1
Authority
EA
Eurasian Patent Office
Prior art keywords
epinastine
high temperature
crystalline modification
obtaining hydrochloride
hydrochloride
Prior art date
Application number
EA200200630A
Other languages
English (en)
Inventor
Рольф Дах
Original Assignee
Бёрингер Ингельхайм Фарма Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Фарма Кг filed Critical Бёрингер Ингельхайм Фарма Кг
Publication of EA200200630A1 publication Critical patent/EA200200630A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

В заявке описывается способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления.Отчет о международном поиске был опубликован 2001.12.06.
EA200200630A 1999-12-03 2000-11-29 Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления EA200200630A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
PCT/EP2000/011942 WO2001040229A2 (de) 1999-12-03 2000-11-29 Verfahren zur herstellung von epinastine-hydrochlorid in der hochschmelzenden kristallmodifikation

Publications (1)

Publication Number Publication Date
EA200200630A1 true EA200200630A1 (ru) 2002-12-26

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200630A EA200200630A1 (ru) 1999-12-03 2000-11-29 Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления

Country Status (23)

Country Link
US (1) US6403790B1 (ru)
EP (1) EP1237892B1 (ru)
JP (1) JP4789383B2 (ru)
KR (1) KR100737191B1 (ru)
CN (1) CN1402728A (ru)
AR (1) AR026678A1 (ru)
AT (1) ATE238306T1 (ru)
AU (1) AU2163501A (ru)
BR (1) BR0016052A (ru)
CA (1) CA2389170C (ru)
CO (1) CO5251470A1 (ru)
CZ (1) CZ20021843A3 (ru)
DE (2) DE19958460A1 (ru)
DK (1) DK1237892T3 (ru)
EA (1) EA200200630A1 (ru)
ES (1) ES2198368T3 (ru)
HU (1) HUP0203501A2 (ru)
IL (1) IL149711A0 (ru)
MX (1) MXPA02005330A (ru)
PL (1) PL355628A1 (ru)
PT (1) PT1237892E (ru)
UY (1) UY26461A1 (ru)
WO (1) WO2001040229A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd ６−（１−ｈ−イミダゾール−１−イル）−７−ニトロ−２，３−（１ｈ，４ｈ）−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Also Published As

Publication number Publication date
WO2001040229A2 (de) 2001-06-07
EP1237892A2 (de) 2002-09-11
DE19958460A1 (de) 2001-06-07
JP2003515536A (ja) 2003-05-07
DK1237892T3 (da) 2003-08-04
CN1402728A (zh) 2003-03-12
ATE238306T1 (de) 2003-05-15
IL149711A0 (en) 2002-11-10
CA2389170C (en) 2008-01-08
DE50001920D1 (de) 2003-05-28
CO5251470A1 (es) 2003-02-28
MXPA02005330A (es) 2003-01-28
UY26461A1 (es) 2001-07-31
US6403790B1 (en) 2002-06-11
CA2389170A1 (en) 2001-06-07
ES2198368T3 (es) 2004-02-01
PT1237892E (pt) 2003-08-29
EP1237892B1 (de) 2003-04-23
JP4789383B2 (ja) 2011-10-12
AU2163501A (en) 2001-06-12
HUP0203501A2 (hu) 2003-03-28
KR20020058080A (ko) 2002-07-12
KR100737191B1 (ko) 2007-07-10
WO2001040229A3 (de) 2001-12-06
PL355628A1 (en) 2004-05-04
AR026678A1 (es) 2003-02-19
BR0016052A (pt) 2002-07-23
CZ20021843A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
EA199700262A1 (ru) Способ получения 2-метилтиенобензодиазепина и его кристаллические формы
NO990761D0 (no) FremgangsmÕte for drift av et kraftverksanlegg med en CO2 -prosess
NO991978D0 (no) FremgangsmÕte for drift av et kraftverk med en CO2-prosess
BR9508618A (pt) Processo integrado para a produção de lacteto
IS5471A (is) Aðferð til framleiðslu á afleiðum af taxóíða flokknum
ID28724A (id) Proses untuk memproduksi sikloalkanon
BR9914787A (pt) Processo para a preparação de um composto
EA200200630A1 (ru) Способ получения гидрохлорида эпинастина в виде кристаллической модификации с высокой температурой плавления
ID19244A (id) Produksi kapur kembang
FR2779806B1 (fr) Bruleur a injecteur perfectionne et procede de fabrication de cet injecteur
HK1029306A1 (en) Spectacle lens, drilling method for spectacle lensand manufacture jig thereof.
NO20011804D0 (no) En forbedret fremgangsmåte for fremstilling av nye antidiabetiske midler
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
DK0857206T3 (da) Krystallinsk cellulase samt fremgangsmåde til fremstilling af samme
EA199900741A1 (ru) Способ получения эпросартана
EA200400211A1 (ru) Лиофилизованная композиция 2-метилтиенобензодиазепина
ID21499A (id) Proses untuk memproduksi n-(4-fluorofenil)-n-(1-metiletil)-2-[(5-(trifluorometil)-1,3,4-tiadiazol-2-il)-oksi]-asetamida
ID22382A (id) Metoda untuk menghasilkan tanaman pelindung dengan kultur fotoautotropik
FR2782517B1 (fr) Procede de fabrication d'hexafluorophosphate de lithium
ITMI982857A0 (it) Processo per la sintesi di 5-(a-idrossialchil)benzo[1,3]diossoli
ID27452A (id) Proses untuk membuat urea 1,3-tersubstitusi-4-oksosiklik
ID16207A (id) Proses untuk memproduksi 2,6-dimetilnaftalena dengan kemurnian tinggi
ID21435A (id) Proses untuk memproduksi suatu kaprolaktam dengan kemurnian tinggi
FR2783821B1 (fr) Procede de fabrication du difluoroethylene
EA200100864A1 (ru) Способ получения 1,4,7,10-тетраазациклододекана